发明授权
US08835474B2 Remedy for overactive bladder comprising acetic acid anilide derivative as the active ingredient
有权
包括醋酸苯胺衍生物作为活性成分的膀胱活动过度的补救措施
- 专利标题: Remedy for overactive bladder comprising acetic acid anilide derivative as the active ingredient
- 专利标题(中): 包括醋酸苯胺衍生物作为活性成分的膀胱活动过度的补救措施
-
申请号: US13117638申请日: 2011-05-27
-
公开(公告)号: US08835474B2公开(公告)日: 2014-09-16
- 发明人: Toshiyuki Takasu , Shuichi Sato , Masashi Ukai , Tatsuya Maruyama , Masayuki Shibasaki
- 申请人: Toshiyuki Takasu , Shuichi Sato , Masashi Ukai , Tatsuya Maruyama , Masayuki Shibasaki
- 申请人地址: JP Tokyo
- 专利权人: Astellas Pharma Inc.
- 当前专利权人: Astellas Pharma Inc.
- 当前专利权人地址: JP Tokyo
- 代理机构: Fitzpatrick, Cella, Harper & Scinto
- 优先权: JP2002-323792 20021107
- 主分类号: A61K31/426
- IPC分类号: A61K31/426 ; C07D277/40
摘要:
(R)-2-(2-aminothiazol-4-yl)-4′-[2-[(2-hydroxy-2-phenylethyl)amino]ethyl]acetic acid anilide or its salt shows a potent bladder relaxation effect in “isolated rat bladder smooth muscle relaxation test”, dose-dependently lowers the contraction frequency of rhythmic bladder contractions in “rat rhythmic bladder contraction measurement test” and, moreover, prolongs the urination intervals in “urination functions measurement test on cyclophosphamide-induced overactive bladder model rat”. Owing to these effects, the above compound is useful as a remedy for overactive bladder.
公开/授权文献
信息查询
IPC分类: